4-tert-butyl-calix[4]arene-crown-6-complex

Modify Date: 2024-01-16 19:01:27

4-tert-butyl-calix[4]arene-crown-6-complex Structure
4-tert-butyl-calix[4]arene-crown-6-complex structure
Common Name 4-tert-butyl-calix[4]arene-crown-6-complex
CAS Number 129518-51-0 Molecular Weight 680.91200
Density N/A Boiling Point N/A
Molecular Formula C44H56O6 Melting Point N/A
MSDS N/A Flash Point N/A

 Names

Name 4-tert-butyl-calix[4]arene-crown-6-complex
Synonym More Synonyms

 Chemical & Physical Properties

Molecular Formula C44H56O6
Molecular Weight 680.91200
Exact Mass 680.40800
PSA 55.38000
LogP 7.76030

 MSDS

Name: 4-Tert.-Butyl-Calix[4]Arene-Crown-6-Complex Material Safety Data Sheet
Synonym: None Known
CAS: 129518-51-0
Section 1 - Chemical Product MSDS Name:4-Tert.-Butyl-Calix[4]Arene-Crown-6-Complex Material Safety Data Sheet
Synonym:None Known

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
129518-51-0 4-Tert.-Butyl-Calix[4]Arene-Crown-6-Co 95 unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary edema.
Chronic:
Effects may be delayed.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Runoff from fire control or dilution water may cause pollution.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 129518-51-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: white - grey
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Not available.
Specific Gravity/Density:
Molecular Formula: C54H74O8
Molecular Weight: 850.5132

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 129518-51-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Tert.-Butyl-Calix[4]Arene-Crown-6-Complex - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 129518-51-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 129518-51-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 129518-51-0 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Hazard Codes Xi: Irritant;
Risk Phrases R36/37/38
Safety Phrases S26-S37/39

 Synonyms

4-TERT-BUTYLCALIX(4)-CROWN-6
5,11,17,23-tetrakis(1,1-dimethylethyl)-25,27-dihydroxycalix[4]arene-crown-6
2,23,28,38-tetrakis(1,1-dimethylethyl)-6,7,9,10,12,13,15,16,18,19-decahydro-31H-4,21-(methano[1,3]benzenomethano)-26,30-metheno-25H-dibenzo[q,z][1,4,7,10,13,16]hexaoxacycloheptacosin-32,35-diol
p-tert-butylcalix[4]crown-6
Top Suppliers:I want be here
Related Compounds: More...
4-tert-butyl-calix[4]arene-crown-5-complex
99314-01-9
4-tert-butyl-calix[4]arene-crown-4-complex
171058-95-0
4-tert-butyl-calix[4]arene tetra-n-propyl ether
135269-36-2
5,11,17,23-tetra-tert-butyl-25,26,27,28-tetrakis[(ethoxycarbonyl)methoxy]-2,8,14,20-calix[4]arene
121702-03-2
5,11,17,23-tetra-tert-butyl-25,27-dibenzoyloxy-26,28-dihydroxycalix[4]arene
161316-47-8
25-(1-chloro-3,6-dioxaoct-8-yl)oxy-26,27,28-trihydroxy-5,11,17,23-tetra-tert-butyl-calix[4]arene
727720-21-0
tert-Butyl-calix[4]arene tetrakis[2-(diphenylphosphoryl)ethyl ether]
171979-66-1
25,27-bis[(hydroxycarbonyl)methoxy]calix[4]arene-crown-6
319492-47-2
25,27-bis(2-hydroxyethoxy)calix[4]arene-crown-6
162209-40-7
(3R)-3-(4-Fluorophenyl)-4-(phenylmethyl)-2-morpholinone
219821-32-6
(I+/-R,I(2)S)-4-Bromo-I+/--methyl-I(2)-(nitromethyl)benzenepropanal
864466-72-8
8-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline
171066-27-6
1-(3-{[5-Carbamoyl-6-(3,4-difluoro-phenyl)-4-ethyl-2-oxo-3,6-dihydro-2H-pyrimidine-1-carbonyl]-amino}-propyl)-4-phenyl-piperidine-4-carboxylic acid methyl ester
252201-38-0
5-[4-Aminomethyl-3,5-dimethoxyphenoxy]-pentanoic acid
125666-66-2
2-([(4-Chlorophenyl)sulfanyl]methyl)pyrrolidine
1248823-61-1
3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol
80374-25-0
N-[(4-benzylmorpholin-2-yl)methyl]-2,2,2-trifluoroacetamide
116163-26-9
1-(4-chlorophenyl)-5-[(2,4-dichlorophenoxy)methyl]-1H-tetrazole
912904-06-4
1-hydroxy-3H-2,1$l^{5}-benzoxaphosphole 1-oxide
75777-32-1